COVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street’s first-quarter expectations, as the drugmaker’s profit grew 61 percent, Your Content has learned.
Pfizer on Tuesday posted net income of $7.86 billion, up 61% from last year.
COVID-19 vaccine Comirnatybrought in $13 billion in sales in the quarter.
Pill treatment Paxlovid, which launched late last year, added another $1.5 billion,‘according to The Daily Mail.
Your Content for the latest updates. Have a story or news tip? Contact our 24/7 newsroom at 833.336.8013 or e-mail our tip line: [email protected]